Clinical Trial Update: The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the effect of GLP-1 on postprandial glucagon secretion independent of gastric emptying in individuals with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Type 1 Diabetes | Phase 2, Phase 3 | Status: UNKNOWN